D
Donal J. Brennan
Researcher at Mater Misericordiae University Hospital
Publications - 150
Citations - 7861
Donal J. Brennan is an academic researcher from Mater Misericordiae University Hospital. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 42, co-authored 129 publications receiving 6598 citations. Previous affiliations of Donal J. Brennan include University College Dublin & Mater Health Services.
Papers
More filters
methylation and regulates tumor growth in hematopoietic malignancies
Elin Gustavsson,Sandra Sernbo,Elin Andersson,Donal J. Brennan,Michael Dictor,Mats Jerkeman,Carl A.K. Borrebaeck,Sara Ek +7 more
TL;DR: The data show that SOX11 is not a bystander but an active and central regulator of cellular growth, as both siRNA-mediated knock-down and ectopic overexpression of SoX11 resulted in altered proliferation.
Journal ArticleDOI
Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: A metanalysis.
TL;DR: MIS hysterectomy is associated with improved QoL in the short term post-operative phase compared to AH both for benign disease and endometrial cancer.
Journal ArticleDOI
Maternal morbidity in placenta accreta spectrum following introduction of a multi-disciplinary service compared to standard care: an Irish perspective
Helena C. Bartels,Karen M. Mulligan,Simon Craven,Ailín C. Rogers,Shane Higgins,D. O'Brien,Ruaidhri McVey,Peter McParland,Jennifer M. Walsh,Stephen Carroll,Siobhan Corcoran,Mike Robson,Rhona Mahony,Paul Downey,David P. Brophy,Gabrielle C. Colleran,Fionnuala M. McAuliffe,Donal J. Brennan +17 more
TL;DR: In this paper, the authors compared maternal outcomes in patients with placenta accreta spectrum (PAS) when managed as part of a multi-disciplinary team (MDT) compared to standard care.
Journal Article
Carbonic anhydrase IX is a new independent prognostic marker in pre-menopausal breast cancer patients with 1 to 3 positive lymph nodes
Donal J. Brennan,Asa Kronblad,Karin Jirström,Goran Landberg,Michael J. Duffy,William M. Gallagher,Sallyann L. O Brien +6 more
TL;DR: It is suggested that inhibition of CA IX may be a useful method of increasing the radiosensitivity of such tumors in patients with one to three positive lymph nodes as all of these patients received locoregional radiotherapy.
Journal ArticleDOI
Short-term outcomes in older patients with peritoneal malignancy treated with cytoreductive surgery and HIPEC: Experience with 245 patients from a national centre.
Alan Keyes,Michael E. Kelly,Niall McInerney,Mohammad Faraz Khan,Jarlath C Bolger,Emilie Mccormack,Josh Grundy,Orla McCormack,John MacHale,John Conneely,Donal J. Brennan,Ronan A. Cahill,Conor Shields,Brendan Moran,Jurgen Mulsow +14 more
TL;DR: In this paper, a retrospective review of a prospective database of all patients who underwent CRS with HIPEC in a single institution over seven years was performed, and a comparative analysis of outcomes in patients under 65 undergoing CRS and HIPEC with patients ≥ 65 years were performed.